<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Survival in patients who develop symptomatic severe aortic stenosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Survival in patients who develop symptomatic severe aortic stenosis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Survival in patients who develop symptomatic severe aortic stenosis</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This graph demonstrates the survival of patients with untreated and treated calcific AS. Prior to the onset of symptoms, patients with calcific aortic valve disease are at risk of cardiovascular morbidity and mortality given associated comorbidities (eg, risk of coronary artery disease). Hence, mortality for patients with asymptomatic calcific AS is higher than for the general population. For patients with severe AS, the outlook dramatically worsens when symptoms develop (eg, dyspnea of cardiac origin, syncope, or angina pectoris) and untreated patients exhibit mortality rates that approach 50% in 2 years. In patients with symptomatic severe AS, SAVR or TAVI are associated with short-term procedural risk but provide improved longer-term survival.</div><div class="graphic_footnotes">SAVR: surgical aortic valve replacement; TAVI: transcatheter aortic valve implantation; AS: aortic stenosis.</div><div id="graphicVersion">Graphic 83004 Version 19.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
